Helius Medical Technologies Inc (NASDAQ: HSDT) is 26.81% higher on its value in year-to-date trading and has touched a low of $0.37 and a high of $9.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HSDT stock was last observed hovering at around $0.69 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $0.85, the stock is 20.58% and 40.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 24.42 million and changing 22.83% at the moment leaves the stock -37.16% off its SMA200. HSDT registered -88.51% loss for a year compared to 6-month loss of -0.93%. The firm has a 50-day simple moving average (SMA 50) of $0.5961 and a 200-day simple moving average (SMA200) of $1.37764.
The stock witnessed a 59.13% gain in the last 1 month and extending the period to 3 months gives it a 77.12%, and is 16.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.30% over the week and 22.05% over the month.
Helius Medical Technologies Inc (HSDT) has around 22 employees, a market worth around $3.17M and $0.50M in sales. Profit margin for the company is -1764.74%. Distance from 52-week low is 127.88% and -91.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-233.19%).
with sales reaching $100k over the same period.The EPS is expected to grow by 61.26% this year, but quarterly earnings will post -27.33% year-over-year. Quarterly sales are estimated to shrink -25.37% in year-over-year returns.
16.0 institutions hold shares in Helius Medical Technologies Inc (HSDT), with institutional investors hold 5.90% of the company’s shares. The shares outstanding are 3.73M, and float is at 3.68M with Short Float at 6.25%. Institutions hold 5.87% of the Float.
